Resistin's, Obesity and Insulin Resistance: the Continuing Disconnect Between Rodents and Humans

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2015 Dec 15

PMID 26662574

Citations 47

Authors

X Huang

Z Yang

Affiliations

Soon will be listed here.

Abstract

Purpose: This review aimed to discuss the conflicting findings from resistin research in rodents and humans as well as recent advances in our understanding of resistin's role in obesity and insulin resistance.

Methods: A comprehensive review and synthesis of resistin's role in obesity and insulin resistance as well as conflicting findings from resistin research in rodents and humans.

Results: In rodents, resistin is increased in high-fat/high-carbohydrate-fed, obese states characterized by impaired glucose uptake and insulin sensitivity. Resistin plays a causative role in the development of insulin resistance in rodents via 5' AMP-activated protein kinase (AMPK)-dependent and AMPK-independent suppressor of cytokine signaling-3 (SOCS-3) signaling. In contrast to rodents, human resistin is primarily secreted by peripheral-blood mononuclear cells (PBMCs) as opposed to white adipocytes. Circulating resistin levels have been positively associated with central/visceral obesity (but not BMI) as well as insulin resistance, while other studies show no such association. Human resistin has a role in pro-inflammatory processes that have been conclusively associated with obesity and insulin resistance. PBMCs, as well as vascular cells, have been identified as the primary targets of resistin's pro-inflammatory activity via nuclear factor-κB (NF-κB, p50/p65) and other signaling pathways.

Conclusion: Mounting evidence reveals a continuing disconnect between resistin's role in rodents and humans due to significant differences between these two species with respect to resistin's gene and protein structure, differential gene regulation, tissue-specific distribution, and insulin resistance induction as well as a paucity of evidence regarding the resistin receptor and downstream signaling mechanisms of action.

Citing Articles

Is there a causal relationship between resistin levels and bone mineral density, fracture occurrence? A mendelian randomization study.

Xu T, Li C, Liao Y, Xu Y, Fan Z, Zhang X PLoS One. 2024; 19(8):e0305214.

PMID: 39190724 PMC: 11349205. DOI: 10.1371/journal.pone.0305214.

The Function and Mechanism of Long Noncoding RNAs in Adipogenic Differentiation.

Chen J, Pan Y, Lu Y, Fang X, Ma T, Chen X Genes (Basel). 2024; 15(7).

PMID: 39062654 PMC: 11275360. DOI: 10.3390/genes15070875.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

Arron H, Marsh B, Kell D, Khan M, Jaeger B, Pretorius E Front Immunol. 2024; 15:1386607.

PMID: 38887284 PMC: 11180809. DOI: 10.3389/fimmu.2024.1386607.

Bioinformatics study of the potential therapeutic effects of ginsenoside Rh3 in reversing insulin resistance.

Wang Y, Wu D, Wang Y, Sun J, Wang X, Huang Y Front Mol Biosci. 2024; 11:1339973.

PMID: 38845779 PMC: 11153663. DOI: 10.3389/fmolb.2024.1339973.

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals.

Kosciuszko M, Buczynska A, Luka K, Duraj E, Zuk-Czerniawska K, Adamska A Front Pharmacol. 2024; 15:1329802.

PMID: 38655176 PMC: 11035812. DOI: 10.3389/fphar.2024.1329802.

References

Yang R, Huang Q, Xu A, McLenithan J, Eisen J, Shuldiner A . Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun. 2003; 310(3):927-35. DOI: 10.1016/j.bbrc.2003.09.093. View

Manduteanu I, Pirvulescu M, Gan A, Stan D, Simion V, Dragomir E . Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells. Biochem Biophys Res Commun. 2009; 391(3):1443-8. DOI: 10.1016/j.bbrc.2009.12.089. View

Higashida K, Fujimoto E, Higuchi M, Terada S . Effects of alternate-day fasting on high-fat diet-induced insulin resistance in rat skeletal muscle. Life Sci. 2013; 93(5-6):208-13. DOI: 10.1016/j.lfs.2013.06.007. View

Daquinag A, Zhang Y, Amaya-Manzanares F, Simmons P, Kolonin M . An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell. 2011; 9(1):74-86. DOI: 10.1016/j.stem.2011.05.017. View

Xu J, Sham P, Xu A, Tso A, Wat N, Cheng K . Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study. Clin Endocrinol (Oxf). 2007; 66(2):211-7. DOI: 10.1111/j.1365-2265.2006.02710.x. View

Ikeda Y, Tsuchiya H, Hama S, Kajimoto K, Kogure K . Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2014; 448(2):129-33. DOI: 10.1016/j.bbrc.2014.03.076. View

Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H . Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care. 2007; 30(6):1501-6. DOI: 10.2337/dc06-1936. View

Rajala M, Obici S, Scherer P, Rossetti L . Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003; 111(2):225-30. PMC: 151868. DOI: 10.1172/JCI16521. View

Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham N . Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005; 334(4):1092-101. DOI: 10.1016/j.bbrc.2005.06.202. View

10.

Abate N, Sallam H, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P . Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome. Curr Pharm Des. 2013; 20(31):4961-9. DOI: 10.2174/1381612819666131206103102. View

11.

McTernan C, McTernan P, Harte A, Levick P, Barnett A, Kumar S . Resistin, central obesity, and type 2 diabetes. Lancet. 2002; 359(9300):46-7. DOI: 10.1016/s0140-6736(02)07281-1. View

12.

de Luis D, Terroba M, Cuellar L, Conde R, Primo D, Aller R . Resistin levels in morbid obese patients following the biliopancreatic diversion surgery. Horm Metab Res. 2011; 43(3):205-8. DOI: 10.1055/s-0030-1270529. View

13.

Song R, Wang X, Mao Y, Li H, Li Z, Xu W . Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β. Gene. 2013; 529(1):50-6. PMC: 3897445. DOI: 10.1016/j.gene.2013.06.085. View

14.

Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A . Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003; 11(8):997-1001. DOI: 10.1038/oby.2003.137. View

15.

Kahn B, Flier J . Obesity and insulin resistance. J Clin Invest. 2000; 106(4):473-81. PMC: 380258. DOI: 10.1172/JCI10842. View

16.

Minn A, Patterson N, Pack S, Hoffmann S, Gavrilova O, Vinson C . Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun. 2003; 310(2):641-5. DOI: 10.1016/j.bbrc.2003.09.061. View

17.

Kalueff A, Wheaton M, Murphy D . What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007; 179(1):1-18. DOI: 10.1016/j.bbr.2007.01.023. View

18.

Wolfe B, Jimerson D, Orlova C, Mantzoros C . Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004; 61(3):332-8. DOI: 10.1111/j.1365-2265.2004.02101.x. View

19.

Kusminski C, McTernan P, Kumar S . Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond). 2005; 109(3):243-56. DOI: 10.1042/CS20050078. View

20.

Savage D, Sewter C, Klenk E, Segal D, Vidal-Puig A, Considine R . Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001; 50(10):2199-202. DOI: 10.2337/diabetes.50.10.2199. View